Mycenax Biotech Inc.(TW:4726)
NT$22.40-0.60 (-2.61%)
TW:4726
Mycenax Biotech Inc. Revenue
NT$22.40
At close:-0.60 (-2.61%)
Mycenax Biotech Inc. (4726) Revenue
Mycenax Biotech Inc. Revenue
Mycenax Biotech Inc. had a revenue of 203.09M in the quarter ending Jun 30, 2026, with 3.19%. This bring the company's revenue in the last twelve months to 815.87M, Increased 0.07%. In the fiscal year ending Dec 31, 2025, Mycenax Biotech Inc. had annual revenue of 740.24M with 8.23% growth.
- Revenue (ttm)
- 815.87M
- Revenue Growth
- 52.81%
- P/S Ratio
- 6.43
- Revenue/Employee
- TWD 1,912,760
- Employees
- 387
- Market Cap
- TWD 4.76B
Revenue Chart
Mycenax Biotech Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 740.24M | 56.31M | 8.23% |
| Dec 31, 2024 | 683.92M | 31.30M | 4.80% |
| Dec 31, 2023 | 652.62M | -79.66M | -10.88% |
| Dec 31, 2022 | 732.28M | -41.99M | -5.42% |
| Dec 31, 2021 | 774.27M | 108.93M | 16.37% |
| Dec 31, 2020 | 665.34M | 274.50M | 70.23% |
| Dec 31, 2019 | 390.84M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.